BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21667035)

  • 1. Stage II/III cancer of the rectosigmoid junction: an independent tumor type?
    Mukai M; Kishima K; Yamazaki M; Aoki H; Izumi H; Yamamoto S; Tajima T; Tobita K; Sadahiro S; Yasuda S; Ogoshi K
    Oncol Rep; 2011 Sep; 26(3):737-41. PubMed ID: 21667035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the T1/2N1 (≤3 nodes) category actually stage IIIA (TNM)/IIIa (Japanese classification) in patients with primary colorectal cancer?
    Mukai M; Kishima K; Fukumitsu H; Sekido Y; Izumi H; Hoshikawa T; Tajima T; Tobita K; Sadahiro S; Yasuda S; Ogoshi K
    Oncol Rep; 2011 Jul; 26(1):209-14. PubMed ID: 21519799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
    Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
    Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea.
    Kim KH; Yang SS; Yoon YS; Lim SB; Yu CS; Kim JC
    Colorectal Dis; 2011 Aug; 13(8):e220-6. PubMed ID: 21689314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer.
    Segelman J; Singnomklao T; Hellborg H; Martling A
    Colorectal Dis; 2009 Sep; 11(7):768-74. PubMed ID: 18662241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hand-assisted laparoscopic colon and rectal cancer surgery: feasibility, short-term, and oncological outcomes.
    Pendlimari R; Holubar SD; Pattan-Arun J; Larson DW; Dozois EJ; Pemberton JH; Cima RR
    Surgery; 2010 Aug; 148(2):378-85. PubMed ID: 20633732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of right- and left-sided colonic and rectal cancer following surgical resection.
    Suttie SA; Shaikh I; Mullen R; Amin AI; Daniel T; Yalamarthi S
    Colorectal Dis; 2011 Aug; 13(8):884-9. PubMed ID: 20594201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
    Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
    Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer.
    Kobayashi H; Ueno H; Hashiguchi Y; Mochizuki H
    Surgery; 2006 Apr; 139(4):516-22. PubMed ID: 16627061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
    Fietkau R; Zettl H; Klöcking S; Kundt G
    Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for survival in colorectal cancer patients.
    Laohavinij S; Maneechavakajorn J; Techatanol P
    J Med Assoc Thai; 2010 Oct; 93(10):1156-66. PubMed ID: 20973318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
    Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
    Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer.
    Ito I; Mukai M; Ninomiya H; Kishima K; Tsuchiya K; Tajima T; Nakamura M; Makuuchi H
    Oncol Rep; 2008 Dec; 20(6):1521-6. PubMed ID: 19020736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
    Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
    Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.